These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11240036)

  • 1. Anti-GM(2) IgM antibody-induced complement-mediated cytotoxicity in patients with dysimmune neuropathies.
    Cavanna B; Jiang H; Allaria S; Carpo M; Scarlato G; Nobile-Orazio E
    J Neuroimmunol; 2001 Mar; 114(1-2):226-31. PubMed ID: 11240036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-GM2 IgM antibodies: clinical correlates and reactivity with a human neuroblastoma cell line.
    Cavanna B; Carpo M; Pedotti R; Scarpini E; Meucci N; Allaria S; Scarlato G; Nobile-Orazio E
    J Neuroimmunol; 1999 Feb; 94(1-2):157-64. PubMed ID: 10376949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor cell reactivity mediated by IgM antibodies in sera from melanoma patients vaccinated with GM2 ganglioside covalently linked to KLH is increased by IgG antibodies.
    Livingston P; Zhang S; Adluri S; Yao TJ; Graeber L; Ragupathi G; Helling F; Fleisher M
    Cancer Immunol Immunother; 1997 Jan; 43(6):324-30. PubMed ID: 9067403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies.
    Nobile-Orazio E; Giannotta C; Briani C
    J Neuroimmunol; 2010 Feb; 219(1-2):119-22. PubMed ID: 20006388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral neuropathy associated with anti-GM2 ganglioside antibodies: clinical and immunopathological studies.
    O'Hanlon GM; Veitch J; Gallardo E; Illa I; Chancellor AM; Willison HJ
    Autoimmunity; 2000 Sep; 32(2):133-44. PubMed ID: 11078160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
    Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement-mediated anti-HIV-1 effect induced by human IgM monoclonal antibody against ganglioside GM2.
    Wu X; Okada N; Momota H; Irie RF; Okada H
    J Immunol; 1999 Jan; 162(1):533-9. PubMed ID: 9886430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine.
    Kitamura K; Livingston PO; Fortunato SR; Stockert E; Helling F; Ritter G; Oettgen HF; Old LJ
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2805-9. PubMed ID: 7708728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of serum anti-ganglioside antibodies by latex agglutination assay in Guillain-Barré syndrome: comparison with ELISA.
    Irie S; Saito T; Kanazawa N; Ogino M; Ogino Y; Sakai F
    Intern Med; 2003 Jun; 42(6):490-5. PubMed ID: 12857046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgM anti-GM2 antibodies in patients with multifocal motor neuropathy target Schwann cells and are associated with early onset.
    Budding K; Bos JW; Dijkxhoorn K; de Zeeuw E; Bloemenkamp LM; Zekveld EM; Groen EJN; Jacobs BC; Huizinga R; Goedee HS; Cats EA; Leusen JHW; van den Berg LH; Hack CE; van der Pol WL
    J Neuroinflammation; 2024 Apr; 21(1):100. PubMed ID: 38632654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
    Shimoya K; Ohnishi A; Hashimoto T; Yuki N
    Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyclonal IgM and IgA block in vitro complement deposition mediated by anti-ganglioside antibodies in autoimmune neuropathies.
    Sudo M; Miyaji K; Späth PJ; Morita-Matsumoto K; Yamaguchi Y; Yuki N
    Int Immunopharmacol; 2016 Nov; 40():11-15. PubMed ID: 27567246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The IgM antibody level against ganglioside GM2 correlates to the disease status of HIV-1-infected patients.
    Wu X; Okada N; Goto M; Iwamoto A; Okada H
    Microbiol Immunol; 2000; 44(5):405-10. PubMed ID: 10888361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection.
    Irie S; Saito T; Nakamura K; Kanazawa N; Ogino M; Nukazawa T; Ito H; Tamai Y; Kowa H
    J Neuroimmunol; 1996 Aug; 68(1-2):19-26. PubMed ID: 8784256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute cytomegalovirus infection and IgM anti-GM2 antibody.
    Yuki N; Tagawa Y
    J Neurol Sci; 1998 Jan; 154(1):14-7. PubMed ID: 9543317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgM anti-ganglioside antibodies induced by melanoma cell vaccine correlate with survival of melanoma patients.
    Takahashi T; Johnson TD; Nishinaka Y; Morton DL; Irie RF
    J Invest Dermatol; 1999 Feb; 112(2):205-9. PubMed ID: 9989797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside.
    Livingston PO; Ritter G; Srivastava P; Padavan M; Calves MJ; Oettgen HF; Old LJ
    Cancer Res; 1989 Dec; 49(24 Pt 1):7045-50. PubMed ID: 2582446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay.
    Alaedini A; Briani C; Wirguin I; Siciliano G; D'Avino C; Latov N
    J Neurol Sci; 2002 Apr; 196(1-2):41-4. PubMed ID: 11959155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies?
    Nobile-Orazio E; Gallia F; Terenghi F; Allaria S; Giannotta C; Carpo M
    J Neurol Sci; 2008 Mar; 266(1-2):156-63. PubMed ID: 17915254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barré syndrome.
    Ang CW; Jacobs BC; Brandenburg AH; Laman JD; van der Meché FG; Osterhaus AD; van Doorn PA
    Neurology; 2000 Apr; 54(7):1453-8. PubMed ID: 10751257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.